Phenotypic and molecular characterization of virulence-associated enzymes in Malassezia spp. isolated from companion animals in northern Iran
Abstract
Background and Objectives: Malassezia spp. are lipid-dependent yeasts that colonize the skin of humans and animals and may act as opportunistic pathogens. This study aimed to characterize virulence-associated enzymes and their encoding genes in Malassezia spp. isolated from companion animals in northern Iran.
Materials and Methods: A total of 300 clinical samples were collected from dogs and cats with dermatological or otic lesions. Species identification was performed using ITS-based PCR. Multiplex PCR was used to detect LIP, PLB, and KER genes. Enzymatic activity was evaluated using the Pz index. Statistical analyses included Chi-square and Spearman’s correlation tests (p < 0.05).
Results: Eighty isolates were identified as Malassezia pachydermatis (87.5%) and Malassezia nana (12.5%). LIP, PLB, and KER genes were detected in 90%, 62.5%, and 50% of isolates, respectively. Strong enzymatic activity (Pz ≤ 0.69) was observed in 41.2% of isolates. A significant association was found between the presence of the PLB gene and phospholipase activity.
Conclusion: Malassezia pachydermatis was the predominant species. Virulence-associated genes were associated with higher enzymatic activity, supporting their role in pathogenic potential.
2. Hobi S, Bęczkowski PM, Mueller R, Tse M, Barrs VR. Malassezia dermatitis in dogs and cats. Vet J 2024; 304: 106084.
3. Hobi S, Cafarchia C, Romano V, Barrs VR. Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals. J Fungi (Basel) 2022; 8: 708.
4. Billamboz M, Jawhara S. Anti-Malassezia drug Candidates based on virulence Factors of Malassezia-associated diseases. Microorganisms 2023; 11: 2599.
5. Velegraki A, Cafarchia C, Gaitanis G, Iatta R, Boekhout T. Malassezia infections in humans and animals. PLoS Pathog 2015; 11(1): e1004523.
6. Dropsy H, Cozar A, De Jaeger X, Billy C, Noli C, Cristante R, et al. Evaluation of the performance of topical products containing Ophytrium and chlorhexidine digluconate in cats with local cutaneous bacterial and/or Malassezia pachydermatis overgrowth. J Feline Med Surg 2025;27(4):1098612X251324174.
7. Medeiros P, Canato D, Braz AS, Paulino LC. Phylogenetic analyses reveal insights into interdomain horizontal gene transfer of microbial lipases. Mol Phylogenet Evol 2024; 195: 108069.
8. Hamdino M, Saudy AA, El-Shahed LH, Taha M. Identification of Malassezia species isolated from some Malassezia-associated skin diseases. J Mycol Med 2022; 32: 101301.
9. Bajwa J. Malassezia species and its significance in canine skin disease. Can Vet J 2023; 64: 87-90.
10. Hadrich I, Khemekhem N, Neji S, Trabelsi H, Ilahi A, Sellami H, et al. Production and quantification of virulence factors in Malassezia species. Pol J Microbiol 2022; 71: 529-538.
11. Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol 2008; 128: 345-351.
12. Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg 2018; 126: 1763-1768.
13. Castellá G, De Bellis F, Bond R, Cabañes FJ. Molecular characterization of Malassezia nana isolates from cats. Vet Microbil 2011; 148:363-367.
14. Coutinho SD. Malassezia pachydermatis: enzymes production in isolates from external ear canal of dogs with and without otitis. Arq Bras Med Vet Zootec 2005; 57: 149-153.
15. Čonková E, Váczi P, Malinovská Z. Extracellular phospholipase production by Malassezia pachydermatis strains and its inhibition by selected antimycotics and plant essential oil components. Vet Res Commun 2024; 48: 3271-3282.
16. Sparber F, LeibundGut-Landmann S. Host responses to Malassezia species in health and disease. Front Cell Infect Microbiol 2020; 10: 198.
17. Meason-Smith C, Olivry T, Lawhon SD, Hoffmann AR. Malassezia species dysbiosis in natural and allergen-induced atopic dermatitis in dogs. Med Mycol 2020; 58: 756-765.
18. Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL Jr. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004; 51: 785-798.
19. Teramoto H, Kumeda Y, Yokoigawa K, Hosomi K, Kozaki S, Mukamoto M, et al. Genotyping and characterisation of the secretory lipolytic enzymes of Malassezia pachydermatis isolates collected from dogs. Vet Rec Open 2015; 2(2): e000124.
20. Cafarchia C, Figueredo LA, Iatta R, Colao V, Montagna MT, Otranto D. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Med Mycol 2012; 50: 795-801.
21. Bond R, Morris DO, Guillot J, Bensignor EJ, Robson D, Mason KV, et al. Biology, diagnosis and treatment of Malassezia dermatitis in dogs and cats: Clinical consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 2020; 31: 28-74.
| Files | ||
| Issue | Vol 18 No 4 (2026) | |
| Section | Original Article(s) | |
| Keywords | ||
| Malassezia pachydermatis Malassezia nana Virulence factors Lipase Phospholipase Keratinase | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |



